“…The limitations of cost and sensitivity may be partially overcome by RNA-based sequencing, where the entire coding region can be amplified in just a few overlapping fragments and any abnormalities localized outside of the exonic structure identified. Difficulties in the detection of changes can still be encountered such as alternative splicing [Hori et al, 1992;Arakawa et al, 1994;Charbonnier et al, 1995;Kohonen-Corish et al, 1996;Xia et al, 1996;Mori et al, 1997;Xu et al, 1997;Genuardi et al, 1998;Palmirotta et al, 1998] and low expression of mutant alleles [Lim et al, 1992;Maquat, 1995;Liu et al, 1996;Nyström-Lahti et al, 1996;Andreutti-Zaugg et al, 1997;Jäger et al, 1997;Culbertson, 1999;Wang et al, 1999]. It has been suggested that it is difficult to reliably detect abnormal transcripts of MSH2 or MLH1 in peripheral blood lymphocytes without additional stimulation of their proliferation in tissue culture.…”